Epothilone analogues modified at positions C12-C13 as anticancer drugs

Details for Australian Patent Application No. 2007331722 (hide)

Owner Novartis AG

Inventors Altmann, Karl-Heinz

Agent Davies Collison Cave

Pub. Number AU-A-2007331722

PCT Pub. Number WO2008/071404

Priority 06126141.8 14.12.06 EP

Filing date 12 December 2007

Wipo publication date 19 June 2008

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/424 (2006.01) - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/071404 Priority application(s): WO2008/071404

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007331723-4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides

2007331719-Ceiling driving unit for moving doors